Product Information
PREGABALIN 200 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $0.0593 per EA under NDC 43547051109. Its NADAC has been published 157 times since Oct 4, 2023.
FDA first approved this application on Sep 1, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547051109
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA207883FDA Approved
9/1/2022
TE Code
AB
On Market Since
6/15/2020
Price Statistics
The NADAC for PREGABALIN 200 MG CAPSULE has been published 157 times since Oct 4, 2023, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0593 per EA |
|---|---|
| All-time high | $0.0858 (Dec 13, 2023) |
| All-time low | $0.0552 (Nov 20, 2024) |
| 52-week high | $0.0650 |
| 52-week low | $0.0564 |
| Median price | $0.0650 |
| Average price | $0.0660 |
| Largest weekly change | +25.7% (Aug 21, 2024) |
| Weeks tracked | 157 |
| Tracking since | Oct 4, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pregabalin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREGABALIN 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 200 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $0.0593 per EA (NDC 43547051109), effective Sep 30, 2026.
How has the price of PREGABALIN 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 200 MG CAPSULE has declined 28.0%. It has been tracked across 157 weekly CMS publications since Oct 4, 2023.
What are the highest and lowest recorded NADAC prices for PREGABALIN 200 MG CAPSULE?
Since Oct 4, 2023, the NADAC for PREGABALIN 200 MG CAPSULE has ranged from a low of $0.0552 (Nov 20, 2024) to a high of $0.0858 (Dec 13, 2023), with a median of $0.0650 per EA.
Are there cheaper alternatives to PREGABALIN 200 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PREGABALIN 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PREGABALIN 200 MG CAPSULE?
PREGABALIN 200 MG CAPSULE (NDC 43547051109) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.